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Hypotension is more risky than hypertension in very
old people
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The open label treatment extension of the original HYVET
study received enthusiastic applause as further evidence for
direct and long term benefits of treating hypertension in very
old people (≥80 years).1 However, we should be cautious in
extrapolating these findings to clinical practice.
It has repeatedly been shown that hypotension, not hypertension,
carries the greatest risk in very old people.2 Low blood pressure
may be a consequence of imminent heart failure, drug treatment,
or both, whereas raised blood pressure may be reactive and can
have survival benefits by ensuring perfusion in critical organs.3
It is therefore important to estimate the net benefit of blood
pressure lowering treatment. The latest Cochrane review on
treatment of hypertension in octogenarians weighs all the
available evidence, including the HYVET study, but does not
show a survival benefit for treatment, the hazard ratio being
close to unity.4 The HYVET studymay be the only trial to show
a survival benefit because it recruited healthy octogenarians, as
shown by the low levels of comorbidity at baseline and low
fatality rate in the placebo group.5
The benefits of treating very healthy octogenarians with
hypertension definitely outweigh the side effects. But it would
be a daunting task for clinicians to correctly identify these older
people in clinical practice.
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